SNH.DE Steinhoff Int. (XETRA) €0.159 intraday 12 Jan 2026: Heavy volume outlook

SNH.DE stock is trading at €0.159 intraday on XETRA on 12 Jan 2026, with 16,145,626 shares traded so far and a relative volume of 1.66. That activity puts Steinhoff International Holdings N.V. among the most active names on the German session. Investors are watching valuation metrics — including a negative EPS of -0.23 and a market cap of €670,668,370 — while liquidity and sector trends shape short-term flows.

SNH.DE stock intraday trading snapshot

Steinhoff International (SNH.DE) opened at €0.1523 and is trading between a day low of €0.149 and day high of €0.160. Volume is 16,145,626 versus an average of 9,704,018, signalling above-normal participation in this intraday session. Elevated turnover is consistent with the stock’s listing on XETRA in Germany and the ‘most-active’ strategy focus for traders seeking liquidity and volatility.

SNH.DE stock fundamentals and valuation

On reported metrics Steinhoff shows an EPS of -0.23 and a negative P/E of -0.69, reflecting recent losses and restructuring effects. Key ratios: price-to-sales 0.06, EV/EBITDA 8.62, and enterprise value €13,246,268,370. The company reports a book value per share of -0.88 and cash per share of 0.24, underlining balance-sheet complexity and negative equity measures versus peers in Consumer Cyclical.

SNH.DE stock technicals and market activity

Price sits below the 50-day average (€0.20) and very near the 200-day average (€0.18), a setup traders watch for potential range breaks. The stock’s year high is €0.326 and year low €0.060, showing wide historical volatility. Relative volume of 1.66 and average daily turnover support short-term trading strategies but also raise liquidity-driven headline risk.

SNH.DE stock: Meyka AI grade and model forecast

Meyka AI rates SNH.DE with a score out of 100: 67.97 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 and sector comparisons, financial growth, key metrics, forecasts, and analyst consensus. Meyka AI’s forecast model projects a 1-year target of €0.65, a three-year target of €0.86, and a five-year target of €0.97. Forecasts are model-based projections and not guarantees.

SNH.DE stock risks and opportunities

Opportunities stem from low current pricing, broad retail footprint across regions, and potential operational improvements that could lift margins and cash flow. Risks include negative shareholders’ equity, weak current ratio (0.35), high net debt to EBITDA (8.19), and legacy governance issues that can limit upside. Investors should weigh sector cyclicality versus retail recovery scenarios in Consumer Cyclical.

SNH.DE stock price targets and analyst view

Market-level price targets we track: conservative €0.25 (upside +57.23%), base €0.65 (upside +308.81% vs current €0.159), and bullish €0.97 (upside +510.13%). These targets balance present balance-sheet strain against revenue per share (2.49) and a low price-to-sales ratio. Analysts and active traders should position size carefully given volatility.

Final Thoughts

SNH.DE stock is trading actively on XETRA at €0.159 on 12 Jan 2026, driven by volume well above average (16,145,626). Meyka AI’s modelling points to a 12-month central projection of €0.65, implying +308.81% upside from the current price, while a conservative scenario at €0.25 offers a +57.23% outcome. The company’s negative EPS (-0.23), weak current ratio (0.35), and high net-debt-to-EBITDA (8.19) are material headwinds. For most-active traders the stock offers intraday liquidity and headline-driven moves; for longer-term investors the grade of B (67.97) signals a HOLD bias until clearer earnings recovery and balance-sheet repair occur. Forecasts are model-based projections and not guarantees. For further company detail see Steinhoff’s site and our Meyka AI coverage for real-time updates source Meyka stock page.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.